<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Shop &#8211; Molecule Peptides</title>
	<atom:link href="https://moleculepeptides.com/shop/feed/" rel="self" type="application/rss+xml" />
	<link>https://moleculepeptides.com</link>
	<description></description>
	<lastBuildDate>Fri, 06 Mar 2026 03:25:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://moleculepeptides.com/wp-content/uploads/2026/03/molecule_logo.svg</url>
	<title>Shop &#8211; Molecule Peptides</title>
	<link>https://moleculepeptides.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>5-Amino-1MQ</title>
		<link>https://moleculepeptides.com/product/5-amino-1mq/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 05 Mar 2026 05:39:18 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=530</guid>

					<description><![CDATA[<strong data-start="0" data-end="45" data-is-only-node="">5-Amino-1MQ (5-Amino-1-methylquinolinium)</strong> is a small-molecule compound commonly used in laboratory research investigating <strong data-start="126" data-end="213">nicotinamide N-methyltransferase (NNMT) inhibition and metabolic signaling pathways</strong>. It is studied in experimental models exploring cellular energy metabolism, methylation processes, and metabolic regulatory mechanisms.]]></description>
										<content:encoded><![CDATA[<h1 style="">5-Amino-1MQ</h1>
<p>5-Amino-1MQ (5-Amino-1-methylquinolinium) is a synthetic small-molecule compound belonging to the <strong>quinolinium class of chemical structures</strong>. It is widely utilized in <strong>laboratory and preclinical research</strong> investigating nicotinamide N-methyltransferase (NNMT) activity and the broader metabolic signaling pathways associated with cellular methylation and energy metabolism.</p>
<p>NNMT is an intracellular enzyme responsible for catalyzing the methylation of <strong>nicotinamide</strong>, utilizing <strong>S-adenosylmethionine (SAM)</strong> as a methyl donor to produce <strong>1-methylnicotinamide (MNA)</strong>. In experimental research environments, modulation of NNMT activity is studied for its potential influence on <strong>cellular metabolic balance, methyl donor availability, and NAD⁺-related metabolic pathways</strong>. As a result, compounds such as 5-Amino-1MQ are frequently used in biochemical and cellular research models examining metabolic enzyme regulation and intracellular signaling networks.</p>
<p>Due to its ability to interact with NNMT-associated metabolic pathways, 5-Amino-1MQ is commonly employed in <strong>cell culture experiments and metabolic tissue research models</strong> investigating the relationship between methylation pathways and cellular energy regulation. Preclinical studies have explored how NNMT activity may influence <strong>metabolic signaling networks, gene expression pathways, and cellular metabolic homeostasis</strong> across several biological systems, including adipocyte models and metabolic tissue assays.</p>
<p>In addition to enzyme inhibition studies, research involving 5-Amino-1MQ has examined how alterations in NNMT activity may affect <strong>intracellular metabolite balance, methyl donor utilization, and NAD⁺-related metabolic signaling processes</strong>. These investigations contribute to broader research into the regulatory mechanisms that coordinate cellular metabolism, nutrient signaling, and energy homeostasis within experimental laboratory models.</p>
<p>Rather than acting on a single biological target system, 5-Amino-1MQ is studied as part of broader <strong>metabolic signaling and enzyme-regulation research</strong>, where investigators examine how modulation of metabolic enzymes can influence interconnected biochemical pathways. This has positioned the compound as a useful tool in studies focused on <strong>cellular metabolic regulation, methylation pathway dynamics, and metabolic signaling networks</strong>.</p>
<p>As with many experimental metabolic modulators, the majority of current knowledge surrounding 5-Amino-1MQ derives from <strong>in vitro assays and preclinical research models</strong> that examine enzyme kinetics, cellular metabolic pathways, and intracellular signaling responses. These studies emphasize mechanistic understanding of metabolic enzyme regulation rather than therapeutic outcomes.</p>
<p>5-Amino-1MQ is therefore commonly utilized in laboratory environments studying <strong>metabolic enzyme activity, NAD⁺-associated pathways, and intracellular methylation signaling systems</strong>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cagrilintide</title>
		<link>https://moleculepeptides.com/product/cagrilintide/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 05 Mar 2026 05:31:01 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=528</guid>

					<description><![CDATA[<strong data-start="0" data-end="16" data-is-only-node="">Cagrilintide</strong> is a long-acting synthetic analog of the hormone amylin that is utilized in laboratory research involving metabolic signaling and appetite-regulation pathways. It is commonly studied in preclinical models investigating energy balance, gastric signaling, and neuroendocrine mechanisms associated with metabolic regulation.]]></description>
										<content:encoded><![CDATA[<div style="" class="prose dark:prose-invert inline leading-relaxed break-words min-w-0 [word-break:break-word] prose-strong:font-bold [&amp;_&gt;*:first-child]:mt-0 [&amp;_&gt;*:last-child]:mb-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2"><strong>Cagrilintide</strong></p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Cagrilintide is a long‑acting synthetic analog of amylin, a peptide hormone co‑secreted with insulin by pancreatic β‑cells. It is widely utilized in laboratory and preclinical research investigating metabolic signaling, appetite‑regulation pathways, and neuroendocrine mechanisms involved in energy balance.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">The peptide is structurally modified to enhance receptor engagement and biological half‑life in experimental models, and has been reported to interact with amylin receptor complexes formed by calcitonin receptor (CTR) and receptor activity‑modifying proteins (RAMPs). In laboratory settings, Cagrilintide has been studied for its involvement in central appetite‑regulation signaling, gastric regulatory pathways, and metabolic feedback mechanisms associated with nutrient intake.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Due to its receptor-targeted profile and prolonged activity in preclinical systems, Cagrilintide is frequently used in metabolic and endocrine research models examining signaling interactions between peripheral metabolic hormones and central nervous system regulatory circuits. Preclinical studies have explored how amylin receptor activation may influence satiety signaling networks, gastric emptying pathways, and hypothalamic neuropeptide regulation.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Rather than targeting a single metabolic process, Cagrilintide is studied for its role in integrated metabolic signaling systems, making it a compound of ongoing interest for researchers investigating coordinated regulation of appetite, energy balance, and neuroendocrine metabolic pathways.</p>
<h2 id="peptide-identity-and-molecular-profile" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Peptide Identity and Molecular Profile</h2>
<div class="group relative my-[1em]">
<div class="sticky top-0 z-10 h-0" aria-hidden="true">
<div class="w-full overflow-hidden bg-raised border-x md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest"></div>
</div>
<div class="w-full overflow-auto scrollbar-subtle rounded-lg border md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest bg-raised">
<table class="[&amp;_tr:last-child_td]:border-b-0 my-0 w-full table-auto border-separate border-spacing-0 text-sm font-sans rounded-lg [&amp;_tr:last-child_td:first-child]:rounded-bl-lg [&amp;_tr:last-child_td:last-child]:rounded-br-lg">
<thead class="">
<tr>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Property</strong></th>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Description</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Peptide Name</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Cagrilintide</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Peptide Class</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Synthetic amylin receptor agonist</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Amino Acid Length</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Peptide analog of human amylin (sequence and length may vary by specification)</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Molecular Weight</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Peptide molecular weight in the low‑kilodalton range (see lot‑specific documentation)</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Biological Origin</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Synthetic analog derived from human amylin</td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 id="chemical-and-registry-information" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Chemical and Registry Information</h2>
<div class="group relative my-[1em]">
<div class="sticky top-0 z-10 h-0" aria-hidden="true">
<div class="w-full overflow-hidden bg-raised border-x md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest"></div>
</div>
<div class="w-full overflow-auto scrollbar-subtle rounded-lg border md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest bg-raised">
<table class="[&amp;_tr:last-child_td]:border-b-0 my-0 w-full table-auto border-separate border-spacing-0 text-sm font-sans rounded-lg [&amp;_tr:last-child_td:first-child]:rounded-bl-lg [&amp;_tr:last-child_td:last-child]:rounded-br-lg">
<thead class="">
<tr>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Property</strong></th>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Value</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Molecular Formula</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Defined per specific analog (see certificate of analysis)</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">CAS Number</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">1415456‑99‑3</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">PubChem CID</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">156590429</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Synonyms</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Cagrilintide, AM833</td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 id="biological-pathways-studied-preclinical-research" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Biological Pathways Studied (Preclinical Research)</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">In laboratory and preclinical research environments, Cagrilintide has been investigated for interactions with several metabolic and neuroendocrine signaling pathways.</p>
<div class="group relative my-[1em]">
<div class="sticky top-0 z-10 h-0" aria-hidden="true">
<div class="w-full overflow-hidden bg-raised border-x md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest"></div>
</div>
<div class="w-full overflow-auto scrollbar-subtle rounded-lg border md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest bg-raised">
<table class="[&amp;_tr:last-child_td]:border-b-0 my-0 w-full table-auto border-separate border-spacing-0 text-sm font-sans rounded-lg [&amp;_tr:last-child_td:first-child]:rounded-bl-lg [&amp;_tr:last-child_td:last-child]:rounded-br-lg">
<thead class="">
<tr>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Pathway / System</strong></th>
<th class="border-subtlest p-sm min-w-[48px] break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtle first:border-radius-tl-lg last:border-radius-tr-lg"><strong>Research Context</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Amylin Receptor Signaling</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Studied for interactions with calcitonin receptor/RAMP complexes</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Hypothalamic Appetite Regulation</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Investigated in central nervous system satiety signaling models</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Gastric Signaling Pathways</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Examined in gastric emptying and nutrient‑signaling studies</td>
</tr>
<tr>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Metabolic Feedback Systems</td>
<td class="border-subtlest px-sm min-w-[48px] break-normal border-b border-r last:border-r-0">Explored in endocrine and metabolic regulation research</td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 id="research-applications" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Research Applications</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Cagrilintide is commonly used in laboratory research involving:</p>
<ul class="marker:text-quiet list-disc">
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Metabolic signaling pathway investigations</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Appetite and satiety signaling research</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Neuroendocrine metabolic regulation studies</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Endocrine hormone signaling models</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Energy balance and nutrient signaling research</p>
</li>
</ul>
<h2 id="storage-and-handling-guidelines" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Storage and Handling Guidelines</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Store Cagrilintide in a cool, dry environment protected from light to maintain peptide stability. Appropriate laboratory storage conditions should be maintained to preserve molecular integrity. Handle all research peptides according to standard laboratory safety protocols.</p>
<h2 id="lyophilized-powder" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Lyophilized Powder</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Cagrilintide is supplied in lyophilized powder form, produced through freeze‑drying to remove residual moisture while preserving peptide structure and chemical stability. This format supports accurate measurement and reproducibility in controlled research protocols.</p>
<h2 id="shelf-life-after-reconstitution" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Shelf Life After Reconstitution</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Once reconstituted, Cagrilintide is no longer in its lyophilized state, and its stability characteristics differ from those of the dry powder. In laboratory research environments, reconstituted peptide materials are generally regarded as having a short‑term usable shelf life, commonly measured in days rather than weeks depending on experimental conditions.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Researchers typically account for post‑reconstitution stability as part of experimental planning and quality control procedures. Stability may vary depending on storage conditions and laboratory protocols.</p>
<h2 id="research-use-only" class="font-editorial font-bold mb-2 mt-4 [.has-inline-images_&amp;]:clear-end text-base first:mt-0">Research Use Only</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Cagrilintide is supplied for <strong>research use only</strong> and is not intended for human or veterinary use.</p>
</div>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ARA-290</title>
		<link>https://moleculepeptides.com/product/ara-290/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 05 Mar 2026 05:19:29 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=526</guid>

					<description><![CDATA[<strong data-start="0" data-end="24" data-is-only-node="">ARA-290 (Cibinetide)</strong> is a synthetic peptide derived from the structure of erythropoietin (EPO) that is utilized in laboratory research investigating innate repair receptor (IRR) signaling and cellular protective pathways. It is commonly studied in preclinical models exploring inflammation-related signaling, tissue protection mechanisms, and cellular stress response pathways.]]></description>
										<content:encoded><![CDATA[<h1 style="">ARA-290 (Cibinetide)</h1>
<p>ARA-290 (Cibinetide) is a synthetic peptide derived from the tertiary structure of erythropoietin (EPO), designed to mimic specific signaling regions associated with tissue-protective receptor pathways. It is widely utilized in <strong>laboratory and preclinical research</strong> investigating innate repair receptor (IRR) signaling, inflammatory pathway regulation, and cellular stress response mechanisms.</p>
<p>The peptide is composed of <strong>11 amino acids</strong> and is structurally designed to selectively engage the <strong>innate repair receptor complex</strong>, a heteromeric receptor system formed by the erythropoietin receptor (EPOR) and the β-common receptor (CD131). In experimental research settings, ARA-290 has been studied for its involvement in <strong>cellular protective signaling, inflammatory pathway modulation, and neuroimmune communication mechanisms</strong>.</p>
<p>Due to its receptor specificity and defined signaling profile, ARA-290 is frequently used in <strong>cell culture and preclinical research models</strong> examining tissue response pathways following cellular stress, inflammatory stimuli, and metabolic disruption. Laboratory investigations have explored how activation of innate repair receptor signaling may influence <strong>cytokine pathways, cellular resilience mechanisms, and neuroimmune signaling networks</strong>.</p>
<p>Rather than acting through broad erythropoietic signaling pathways, ARA-290 is studied for its <strong>selective engagement of tissue-protective receptor systems</strong>, making it a compound of ongoing interest in research exploring coordinated cellular repair and inflammatory regulation mechanisms.</p>
<hr />
<h1>Peptide Identity and Molecular Profile</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peptide Name</td>
<td>ARA-290</td>
</tr>
<tr>
<td>Full Name</td>
<td>Cibinetide</td>
</tr>
<tr>
<td>Peptide Class</td>
<td>Synthetic erythropoietin-derived peptide</td>
</tr>
<tr>
<td>Amino Acid Length</td>
<td>11 residues</td>
</tr>
<tr>
<td>Peptide Sequence</td>
<td>QEQLERALNSS</td>
</tr>
<tr>
<td>Molecular Weight</td>
<td>~1,257 Da</td>
</tr>
<tr>
<td>Biological Origin</td>
<td>Synthetic analog derived from erythropoietin receptor-binding region</td>
</tr>
</tbody>
</table>
<hr />
<h1>Chemical and Registry Information</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Molecular Formula</td>
<td>C₅₁H₈₄N₁₆O₂₁</td>
</tr>
<tr>
<td>CAS Number</td>
<td>1208243-50-8</td>
</tr>
<tr>
<td>PubChem CID</td>
<td>25243978</td>
</tr>
<tr>
<td>Synonyms</td>
<td>Cibinetide, ARA-290, EPO-derived peptide</td>
</tr>
</tbody>
</table>
<hr />
<h1>Biological Pathways Studied (Preclinical Research)</h1>
<p>In laboratory and preclinical research environments, ARA-290 has been investigated for interactions with several biological signaling pathways related to cellular protection and inflammatory signaling.</p>
<table>
<thead>
<tr>
<th>Pathway / System</th>
<th>Research Context</th>
</tr>
</thead>
<tbody>
<tr>
<td>Innate Repair Receptor (IRR) Signaling</td>
<td>Studied in relation to EPOR-CD131 receptor complex activation</td>
</tr>
<tr>
<td>Cytokine Signaling Pathways</td>
<td>Investigated for roles in inflammatory signaling modulation</td>
</tr>
<tr>
<td>Neuroimmune Communication</td>
<td>Explored in cellular stress and neuroinflammation models</td>
</tr>
<tr>
<td>Cellular Stress Response</td>
<td>Examined in pathways associated with metabolic and inflammatory stress</td>
</tr>
</tbody>
</table>
<hr />
<h1>Research Applications</h1>
<p>ARA-290 is commonly used in laboratory research involving:</p>
<p>• Neuroimmune signaling studies<br />
• Cellular stress and inflammatory pathway research<br />
• Innate repair receptor signaling investigations<br />
• Cytokine pathway analysis<br />
• Cellular protection mechanisms in experimental models</p>
<hr />
<h1>Storage and Handling Guidelines</h1>
<p>Store ARA-290 in a <strong>cool, dry environment protected from light</strong> to maintain peptide stability. Appropriate laboratory storage conditions should be maintained to preserve molecular integrity. Handle all research peptides using <strong>standard laboratory safety protocols</strong>.</p>
<hr />
<h1>Lyophilized Powder</h1>
<p>ARA-290 is supplied in <strong>lyophilized powder form</strong>, produced through freeze-drying to remove residual moisture while preserving peptide conformation and chemical stability. This format supports accurate measurement and reproducibility in controlled laboratory research protocols.</p>
<hr />
<h1>Shelf Life After Reconstitution</h1>
<p>Once reconstituted, ARA-290 is no longer in its lyophilized state, and its stability characteristics differ from those of the dry powder. In laboratory research environments, reconstituted peptide material is generally regarded as having a <strong>short-term usable shelf life</strong>, commonly measured in <strong>days rather than weeks</strong> depending on experimental conditions.</p>
<p>Researchers typically account for post-reconstitution stability as part of experimental planning and quality control procedures. Stability may vary depending on storage conditions and laboratory protocols.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thymosin Alpha-1</title>
		<link>https://moleculepeptides.com/product/thymosin-alpha-1/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 05 Mar 2026 05:08:47 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=524</guid>

					<description><![CDATA[<strong data-start="0" data-end="26" data-is-only-node="">Thymosin Alpha-1 (Tα1)</strong> is a synthetic peptide derived from thymic proteins that is widely studied in laboratory research involving immune system signaling and cellular regulatory pathways. It is commonly used in experimental models investigating immune modulation, T-cell activity, and cytokine signaling mechanisms.]]></description>
										<content:encoded><![CDATA[<p>&nbsp;</p>
<h1 style="">Thymosin Alpha-1 (Tα1)</h1>
<p>Thymosin Alpha-1 (Tα1) is a synthetic peptide derived from a naturally occurring thymic hormone fragment originally isolated from thymosin fraction 5. It is widely utilized in <strong>laboratory and preclinical research</strong> focused on immune system signaling, cellular regulation, and cytokine-mediated biological pathways.</p>
<p>The peptide consists of <strong>28 amino acids</strong> and is known for its role in research involving <strong>T-cell maturation, antigen presentation processes, and immune signaling networks</strong>. In experimental settings, Thymosin Alpha-1 has been studied for its interactions with immune regulatory pathways that coordinate innate and adaptive immune responses.</p>
<p>Due to its involvement in immune signaling processes, Thymosin Alpha-1 is frequently used in <strong>cell culture and immunology research models</strong> examining cytokine production, dendritic cell activity, and lymphocyte regulation. Preclinical studies have explored how thymic peptides may influence <strong>immune cell differentiation, cellular signaling cascades, and inflammatory pathway regulation</strong> within controlled research environments.</p>
<p>Rather than targeting a single molecular mechanism, Thymosin Alpha-1 is studied for its <strong>broad immunoregulatory signaling behavior</strong>, making it a compound of ongoing interest for researchers investigating complex immune communication networks and host defense signaling pathways.</p>
<hr />
<h1>Peptide Identity and Molecular Profile</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peptide Name</td>
<td>Thymosin Alpha-1</td>
</tr>
<tr>
<td>Full Name</td>
<td>Thymosin α1</td>
</tr>
<tr>
<td>Peptide Class</td>
<td>Synthetic thymic peptide</td>
</tr>
<tr>
<td>Amino Acid Length</td>
<td>28 residues</td>
</tr>
<tr>
<td>Peptide Sequence</td>
<td>Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH</td>
</tr>
<tr>
<td>Molecular Weight</td>
<td>~3,108 Da</td>
</tr>
<tr>
<td>Biological Origin</td>
<td>Synthetic analog of thymic hormone peptide</td>
</tr>
</tbody>
</table>
<hr />
<h1>Chemical and Registry Information</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Molecular Formula</td>
<td>C₁₂₉H₂₁₅N₃₃O₅₅</td>
</tr>
<tr>
<td>CAS Number</td>
<td>62304-98-7</td>
</tr>
<tr>
<td>PubChem CID</td>
<td>16132346</td>
</tr>
<tr>
<td>Synonyms</td>
<td>Thymosin α1, Tα1, Thymalfasin</td>
</tr>
</tbody>
</table>
<hr />
<h1>Biological Pathways Studied (Preclinical Research)</h1>
<p>In laboratory and preclinical research environments, Thymosin Alpha-1 has been studied for interactions with multiple immune regulatory pathways. These investigations focus on <strong>molecular and cellular mechanisms rather than clinical outcomes</strong>.</p>
<table>
<thead>
<tr>
<th>Pathway / System</th>
<th>Research Context</th>
</tr>
</thead>
<tbody>
<tr>
<td>T-Cell Signaling</td>
<td>Studied in relation to T-cell differentiation and activation</td>
</tr>
<tr>
<td>Cytokine Regulation</td>
<td>Investigated in immune signaling and inflammatory pathway models</td>
</tr>
<tr>
<td>Dendritic Cell Activity</td>
<td>Explored in antigen presentation and immune communication studies</td>
</tr>
<tr>
<td>Toll-Like Receptor (TLR) Pathways</td>
<td>Examined in innate immune signaling research</td>
</tr>
<tr>
<td>Immune System Modulation</td>
<td>Studied in models of host defense and immune coordination</td>
</tr>
</tbody>
</table>
<hr />
<h1>Research Applications</h1>
<p>Thymosin Alpha-1 is commonly used in laboratory research involving:</p>
<p>• Immunology and immune signaling studies<br />
• Cytokine pathway investigations<br />
• T-cell maturation and lymphocyte regulation research<br />
• Host defense and immune response models<br />
• Cellular signaling research in immune cell populations</p>
<hr />
<h1>Storage and Handling Guidelines</h1>
<p>Store Thymosin Alpha-1 in a <strong>cool, dry place protected from light</strong> to maintain peptide stability. Appropriate laboratory storage conditions should be maintained to preserve molecular integrity. Handle all research peptides using <strong>standard laboratory safety protocols</strong>.</p>
<hr />
<h1>Lyophilized Powder</h1>
<p>Thymosin Alpha-1 is supplied in <strong>lyophilized powder form</strong>, produced through freeze-drying to remove residual moisture while preserving peptide structure and chemical stability. This format supports accurate measurement and reproducibility in controlled research protocols.</p>
<hr />
<h1>Shelf Life After Reconstitution</h1>
<p>Once reconstituted, Thymosin Alpha-1 is no longer in its lyophilized state, and its stability characteristics differ from those of the dry powder. In laboratory research settings, reconstituted peptide material is typically regarded as having a <strong>short-term usable shelf life</strong>, commonly measured in <strong>days rather than weeks</strong>.</p>
<p>Researchers typically account for post-reconstitution stability as part of experimental planning and laboratory quality control procedures. Stability may vary depending on environmental conditions and storage parameters.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PT-141</title>
		<link>https://moleculepeptides.com/product/pt-141/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 05 Mar 2026 04:38:44 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=520</guid>

					<description><![CDATA[PT-141 (Bremelanotide) is a synthetic peptide studied for its role in melanocortin receptor pathways associated with sexual arousal and neuroendocrine signaling.]]></description>
										<content:encoded><![CDATA[<h1 style="">PT-141 (Bremelanotide)</h1>
<p>PT-141 (Bremelanotide) is a synthetic cyclic peptide derived from modifications of the melanocortin peptide family, particularly analogs of <strong>α-melanocyte-stimulating hormone (α-MSH)</strong>. It is widely utilized in <strong>laboratory and preclinical research</strong> investigating melanocortin receptor signaling, neuroendocrine regulation, and central nervous system pathways.</p>
<p>The peptide belongs to a class of compounds known as <strong>melanocortin receptor agonists</strong>, which interact with receptor subtypes expressed throughout the central nervous system and peripheral tissues. In experimental research settings, PT-141 has been studied primarily for its activity at <strong>melanocortin receptor subtypes MC3R and MC4R</strong>, which are involved in complex regulatory networks including neuroendocrine signaling and autonomic physiological processes.</p>
<p>Due to its receptor selectivity and stable cyclic structure, PT-141 is frequently used in <strong>pharmacological and receptor-binding studies</strong> designed to investigate melanocortin pathway activity and downstream intracellular signaling mechanisms. Preclinical research has explored how melanocortin receptor activation influences <strong>hypothalamic signaling pathways, neurotransmitter systems, and regulatory neuropeptide networks</strong>.</p>
<p>Rather than targeting a single isolated biological process, PT-141 is studied as part of broader <strong>melanocortin system research</strong>, where investigators examine interactions among receptor activation, intracellular signaling cascades, and neuroendocrine regulatory circuits.</p>
<hr />
<h1>Peptide Identity and Molecular Profile</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peptide Name</td>
<td>PT-141</td>
</tr>
<tr>
<td>Full Name</td>
<td>Bremelanotide</td>
</tr>
<tr>
<td>Peptide Class</td>
<td>Synthetic cyclic melanocortin peptide</td>
</tr>
<tr>
<td>Amino Acid Length</td>
<td>7 residues (cyclic heptapeptide)</td>
</tr>
<tr>
<td>Peptide Sequence</td>
<td>Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH</td>
</tr>
<tr>
<td>Molecular Weight</td>
<td>~1,025 Da</td>
</tr>
<tr>
<td>Biological Origin</td>
<td>Synthetic analog derived from α-MSH melanocortin peptides</td>
</tr>
</tbody>
</table>
<hr />
<h1>Chemical and Registry Information</h1>
<table>
<thead>
<tr>
<th>Property</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Molecular Formula</td>
<td>C₅₀H₆₈N₁₄O₁₀</td>
</tr>
<tr>
<td>CAS Number</td>
<td>189691-06-3</td>
</tr>
<tr>
<td>PubChem CID</td>
<td>5282413</td>
</tr>
<tr>
<td>Synonyms</td>
<td>Bremelanotide, PT-141, Melanocortin receptor agonist</td>
</tr>
</tbody>
</table>
<hr />
<h1>Biological Pathways Studied (Preclinical Research)</h1>
<p>In laboratory and preclinical research environments, PT-141 has been investigated for interactions with melanocortin receptor signaling pathways and associated neuroendocrine systems. These studies examine molecular and cellular mechanisms rather than clinical outcomes.</p>
<table>
<thead>
<tr>
<th>Pathway / System</th>
<th>Research Context</th>
</tr>
</thead>
<tbody>
<tr>
<td>Melanocortin Receptor Signaling</td>
<td>Investigated for activation of MC3R and MC4R receptor subtypes</td>
</tr>
<tr>
<td>cAMP Signaling Pathways</td>
<td>Studied for receptor-mediated intracellular signaling cascades</td>
</tr>
<tr>
<td>Neuroendocrine Regulation</td>
<td>Examined within hypothalamic regulatory networks</td>
</tr>
<tr>
<td>Central Nervous System Pathways</td>
<td>Explored in melanocortin-related neuronal signaling models</td>
</tr>
<tr>
<td>Neurotransmitter Systems</td>
<td>Investigated in dopaminergic and autonomic signaling research</td>
</tr>
</tbody>
</table>
<hr />
<h1>Research Applications</h1>
<p>PT-141 is commonly used in laboratory research involving:</p>
<p>• Melanocortin receptor pharmacology<br />
• Neuroendocrine signaling pathway studies<br />
• Hypothalamic regulatory network research<br />
• Central nervous system receptor signaling investigations<br />
• Comparative melanocortin peptide studies</p>
<hr />
<h1>Storage and Handling Guidelines</h1>
<p>Store PT-141 in a <strong>cool, dry environment protected from light</strong> to maintain peptide stability. Appropriate laboratory storage conditions should be maintained to preserve molecular integrity. Handle all research peptides according to <strong>standard laboratory safety protocols</strong>.</p>
<hr />
<h1>Lyophilized Powder</h1>
<p>PT-141 is supplied in <strong>lyophilized powder form</strong>, produced through freeze-drying to remove residual moisture while preserving peptide conformation and chemical stability. This format supports accurate measurement and reproducibility in controlled experimental research protocols.</p>
<hr />
<h1>Shelf Life After Reconstitution</h1>
<p>Once reconstituted, PT-141 is no longer in its lyophilized state, and its stability characteristics differ from those of the dry powder. In laboratory environments, reconstituted peptide materials are typically considered to have a <strong>short-term usable shelf life</strong>, commonly measured in <strong>days rather than weeks</strong>, depending on experimental conditions.</p>
<p>Proper handling, storage temperature, and sterility protocols are important factors influencing peptide stability following reconstitution. Researchers commonly incorporate these considerations into experimental design and quality control procedures.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>KPV Lysine–Proline–Valine</title>
		<link>https://moleculepeptides.com/product/kpv-lysine-proline-valine/</link>
					<comments>https://moleculepeptides.com/product/kpv-lysine-proline-valine/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 17 Feb 2026 16:07:24 +0000</pubDate>
				<guid isPermaLink="false">http://localhost:8888/?post_type=product&#038;p=371</guid>

					<description><![CDATA[KPV is a short synthetic peptide composed of three amino acids (Lysine–Proline–Valine) and is a naturally occurring fragment of α-melanocyte-stimulating hormone (α-MSH). It is widely studied for its role in supporting normal inflammatory balance and cellular signaling pathways.]]></description>
										<content:encoded><![CDATA[<p style="" class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2"><strong>KPV</strong><br />
<strong>Synthetic Tripeptide Research Tool</strong></p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">KPV (Lysine–Proline–Valine) is a naturally occurring C-terminal tripeptide fragment derived from the larger α-melanocyte-stimulating hormone (α-MSH). In preclinical and laboratory research, KPV is investigated for its potential interactions with melanocortin receptors and its modulatory effects on inflammatory and immune signaling pathways.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">In research contexts, KPV is explored as a bioactive peptide with anti-inflammatory and wound-healing properties in vitro, particularly within epithelial and keratinocyte models. Investigations examine its influence on cytokine production, NF-κB signaling, and immune-cell mediated responses. Research applications remain confined to non-clinical, preclinical laboratory settings.</p>
<hr class="bg-subtle h-px border-0" />
<h2 class="mb-2 mt-4 [.has-inline-images_&amp;]:clear-end font-editorial font-bold text-base first:mt-0">Peptide Identity and Molecular Profile</h2>
<div class="group relative my-[1em]">
<div class="w-full overflow-auto rounded-lg md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest bg-raised dark:bg-offset">
<table class="my-0 w-full table-auto border-separate border-spacing-0 text-sm font-sans rounded-lg border-x border-t border-subtler [&amp;_tr:last-child_td:first-child]:rounded-bl-lg [&amp;_tr:last-child_td:last-child]:rounded-br-lg">
<thead class="">
<tr>
<th class="border-subtler p-sm break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtler last:border-radius-tr-lg first:border-radius-tl-lg">Property</th>
<th class="border-subtler p-sm break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtler last:border-radius-tr-lg first:border-radius-tl-lg">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Peptide Name</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">KPV</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Peptide Class</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Synthetic tripeptide, α-MSH C-terminal fragment</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Amino Acid Length</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">3 residues</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Peptide Sequence</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Lys–Pro–Val</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Molecular Weight</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">341.45 Da</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Biological Origin</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Derived fragment of endogenous α-MSH</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Molecular Formula</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">C₁₆H₂₈N₄O₄</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>CAS Number</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">81732-46-9</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>PubChem CID</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">3081391</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Synonyms</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Lys-Pro-Val, α-MSH (11–13), α-Melanotropin tripeptide</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Source Notes</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Synthetic, laboratory-grade, research-use peptide</td>
</tr>
</tbody>
</table>
</div>
<div class="bg-base border-subtler shadow-subtle pointer-coarse:opacity-100 right-xs absolute bottom-xs flex rounded-md border opacity-0 transition-opacity group-hover:opacity-100 [&amp;&gt;*:not(:first-child)]:border-subtle [&amp;&gt;*:not(:first-child)]:border-l">
<div class="flex"></div>
<div class="flex"></div>
</div>
</div>
<hr class="bg-subtle h-px border-0" />
<h2 class="mb-2 mt-4 [.has-inline-images_&amp;]:clear-end font-editorial font-bold text-base first:mt-0">Biological Pathways Studied (Preclinical Research)</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">In laboratory research, KPV is studied for its interactions with inflammatory and melanocortin-associated pathways, including:</p>
<div class="group relative my-[1em]">
<div class="w-full overflow-auto rounded-lg md:max-w-[90vw] border-subtlest ring-subtlest divide-subtlest bg-raised dark:bg-offset">
<table class="my-0 w-full table-auto border-separate border-spacing-0 text-sm font-sans rounded-lg border-x border-t border-subtler [&amp;_tr:last-child_td:first-child]:rounded-bl-lg [&amp;_tr:last-child_td:last-child]:rounded-br-lg">
<thead class="">
<tr>
<th class="border-subtler p-sm break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtler last:border-radius-tr-lg first:border-radius-tl-lg">Pathway / System</th>
<th class="border-subtler p-sm break-normal border-b text-left align-bottom border-r last:border-r-0 font-bold bg-subtler last:border-radius-tr-lg first:border-radius-tl-lg">Research Context</th>
</tr>
</thead>
<tbody>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Inflammatory Cytokine Modulation</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Investigated for suppression of proinflammatory mediators (e.g., TNF-α, IL-1β) in cellular models</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>NF-κB Signaling Pathway</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Studied for potential inhibitory effects on NF-κB translocation and activity</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Epithelial Barrier Integrity</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Examined for restorative properties in keratinocyte and mucosal models</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Melanocortin Receptor Signaling (MC1R)</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Explored for weak agonistic or indirect modulatory interactions</td>
</tr>
<tr>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 "><strong>Tissue Repair and Regeneration</strong></td>
<td class="px-sm border-subtler min-w-[48px] break-normal border-b border-r last:border-r-0 ">Evaluated in preclinical settings for wound healing and epithelial recovery dynamics</td>
</tr>
</tbody>
</table>
</div>
<div class="bg-base border-subtler shadow-subtle pointer-coarse:opacity-100 right-xs absolute bottom-xs flex rounded-md border opacity-0 transition-opacity group-hover:opacity-100 [&amp;&gt;*:not(:first-child)]:border-subtle [&amp;&gt;*:not(:first-child)]:border-l">
<div class="flex"></div>
<div class="flex"></div>
</div>
</div>
<hr class="bg-subtle h-px border-0" />
<h2 class="mb-2 mt-4 [.has-inline-images_&amp;]:clear-end font-editorial font-bold text-base first:mt-0">Research Applications</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">KPV is routinely utilized in preclinical laboratory research for:</p>
<ul class="marker:text-quiet list-disc">
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">In vitro analysis of anti-inflammatory signal modulation</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Studies on epithelial and mucosal tissue physiology</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Investigation of α-MSH fragment bioactivity and receptor cross-reactivity</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Research into peptide-based immunomodulatory mechanisms</p>
</li>
<li class="py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:mb-2 [&amp;&gt;p]:my-0">
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Comparative peptide structure–function relationship studies</p>
</li>
</ul>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2"><strong>Note:</strong> KPV is restricted to preclinical research purposes only. It is not intended for human, therapeutic, veterinary, or diagnostic use. All handling must comply with institutional biosafety regulations.</p>
<hr class="bg-subtle h-px border-0" />
<h2 class="mb-2 mt-4 [.has-inline-images_&amp;]:clear-end font-editorial font-bold text-base first:mt-0">Storage and Handling Guidelines</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">Store KPV as a lyophilized powder in a cool, dry environment, protected from light. Maintain laboratory-standard peptide storage conditions (≤ –20 °C for long-term stability). Handle using approved laboratory peptide safety procedures.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2"><strong>Lyophilized Form:</strong><br />
KPV is supplied in lyophilized form to ensure molecular stability and accurate mass yield for dosing in research experiments.</p>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2"><strong>After Reconstitution:</strong><br />
Reconstituted KPV should be stored according to laboratory best practices. Stability depends on solvent, pH, and temperature; typically suitable for short-term experimental use.</p>
<hr class="bg-subtle h-px border-0" />
<h2 class="mb-2 mt-4 [.has-inline-images_&amp;]:clear-end font-editorial font-bold text-base first:mt-0">Compliance Notice</h2>
<p class="my-2 [&amp;+p]:mt-4 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2">KPV is provided <strong>exclusively for laboratory and preclinical research use</strong>. It is <strong>not approved</strong> for human or veterinary applications. Purchasers are responsible for proper storage, handling, and compliance with all institutional and regional regulations governing research peptides.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://moleculepeptides.com/product/kpv-lysine-proline-valine/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Melanotan II</title>
		<link>https://moleculepeptides.com/product/melanotan-ii/</link>
					<comments>https://moleculepeptides.com/product/melanotan-ii/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 23:52:06 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=267</guid>

					<description><![CDATA[Melanotan II is a synthetic peptide that may support enhanced tanning and skin pigmentation. Available in 10mg size.]]></description>
										<content:encoded><![CDATA[<h2 style="" data-start="219" data-end="236">Melanotan II</h2>
<p data-start="237" data-end="272"><strong data-start="237" data-end="272">Synthetic Peptide Research Tool</strong></p>
<p data-start="274" data-end="536">Melanotan II is a <strong data-start="292" data-end="376">synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH)</strong>. It is utilized in laboratory and preclinical research to study <strong data-start="441" data-end="533">melanocortin receptor signaling, melanocyte biology, and related neuroendocrine pathways</strong>.</p>
<p data-start="538" data-end="995">In preclinical studies, Melanotan II is investigated as a <strong data-start="596" data-end="662">ligand for melanocortin receptors (MC1R, MC3R, MC4R, and MC5R)</strong>, enabling exploration of intracellular signaling mechanisms, receptor activation dynamics, and downstream cyclic AMP (cAMP) pathways in cellular and animal models. Research focuses on <strong data-start="847" data-end="949">molecular interactions, receptor-mediated signal transduction, and physiological response modeling</strong>, without implying therapeutic applications.</p>
<hr data-start="997" data-end="1000" />
<h2 data-start="1002" data-end="1043">Peptide Identity and Molecular Profile</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1045" data-end="1407">
<thead data-start="1045" data-end="1071">
<tr data-start="1045" data-end="1071">
<th data-start="1045" data-end="1056" data-col-size="sm">Property</th>
<th data-start="1056" data-end="1071" data-col-size="md">Description</th>
</tr>
</thead>
<tbody data-start="1099" data-end="1407">
<tr data-start="1099" data-end="1130">
<td data-start="1099" data-end="1114" data-col-size="sm">Peptide Name</td>
<td data-col-size="md" data-start="1114" data-end="1130">Melanotan II</td>
</tr>
<tr data-start="1131" data-end="1189">
<td data-start="1131" data-end="1147" data-col-size="sm">Peptide Class</td>
<td data-col-size="md" data-start="1147" data-end="1189">Synthetic cyclic peptide, α-MSH analog</td>
</tr>
<tr data-start="1190" data-end="1246">
<td data-start="1190" data-end="1210" data-col-size="sm">Amino Acid Length</td>
<td data-col-size="md" data-start="1210" data-end="1246">7 residues (cyclic heptapeptide)</td>
</tr>
<tr data-start="1247" data-end="1313">
<td data-start="1247" data-end="1266" data-col-size="sm">Peptide Sequence</td>
<td data-col-size="md" data-start="1266" data-end="1313">Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂</td>
</tr>
<tr data-start="1314" data-end="1346">
<td data-start="1314" data-end="1333" data-col-size="sm">Molecular Weight</td>
<td data-col-size="md" data-start="1333" data-end="1346">1025.2 Da</td>
</tr>
<tr data-start="1347" data-end="1407">
<td data-start="1347" data-end="1367" data-col-size="sm">Biological Origin</td>
<td data-col-size="md" data-start="1367" data-end="1407">Synthetic analog of endogenous α-MSH</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1409" data-end="1412" />
<h2 data-start="1414" data-end="1450">Chemical and Registry Information</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1452" data-end="1734">
<thead data-start="1452" data-end="1472">
<tr data-start="1452" data-end="1472">
<th data-start="1452" data-end="1463" data-col-size="sm">Property</th>
<th data-start="1463" data-end="1472" data-col-size="md">Value</th>
</tr>
</thead>
<tbody data-start="1494" data-end="1734">
<tr data-start="1494" data-end="1529">
<td data-start="1494" data-end="1514" data-col-size="sm">Molecular Formula</td>
<td data-col-size="md" data-start="1514" data-end="1529">C₅₀H₆₁N₁₁O₈</td>
</tr>
<tr data-start="1530" data-end="1558">
<td data-start="1530" data-end="1543" data-col-size="sm">CAS Number</td>
<td data-col-size="md" data-start="1543" data-end="1558">121062-08-6</td>
</tr>
<tr data-start="1559" data-end="1585">
<td data-start="1559" data-end="1573" data-col-size="sm">PubChem CID</td>
<td data-col-size="md" data-start="1573" data-end="1585">16132784</td>
</tr>
<tr data-start="1586" data-end="1665">
<td data-start="1586" data-end="1597" data-col-size="sm">Synonyms</td>
<td data-start="1597" data-end="1665" data-col-size="md">MT-II, Melanotan II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂</td>
</tr>
<tr data-start="1666" data-end="1734">
<td data-start="1666" data-end="1681" data-col-size="sm">Source Notes</td>
<td data-col-size="md" data-start="1681" data-end="1734">Synthetic, laboratory-grade, research-use peptide</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1736" data-end="1739" />
<h2 data-start="1741" data-end="1794">Biological Pathways Studied (Preclinical Research)</h2>
<p data-start="1796" data-end="1977">In laboratory and preclinical research, Melanotan II has been investigated for <strong data-start="1875" data-end="1965">mechanistic interactions with melanocortin receptors and downstream signaling pathways</strong>, including:</p>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1979" data-end="2608">
<thead data-start="1979" data-end="2018">
<tr data-start="1979" data-end="2018">
<th data-start="1979" data-end="1998" data-col-size="md">Pathway / System</th>
<th data-start="1998" data-end="2018" data-col-size="md">Research Context</th>
</tr>
</thead>
<tbody data-start="2057" data-end="2608">
<tr data-start="2057" data-end="2197">
<td data-start="2057" data-end="2103" data-col-size="md">Melanocortin Receptor Signaling (MC1R–MC5R)</td>
<td data-col-size="md" data-start="2103" data-end="2197">Studied for G-protein coupled receptor activation and cAMP-mediated intracellular cascades</td>
</tr>
<tr data-start="2198" data-end="2280">
<td data-start="2198" data-end="2217" data-col-size="md">cAMP/PKA Pathway</td>
<td data-col-size="md" data-start="2217" data-end="2280">Investigated for receptor-mediated second messenger effects</td>
</tr>
<tr data-start="2281" data-end="2370">
<td data-start="2281" data-end="2305" data-col-size="md">Pigmentation Pathways</td>
<td data-col-size="md" data-start="2305" data-end="2370">Explored in melanocyte models for melanin synthesis signaling</td>
</tr>
<tr data-start="2371" data-end="2482">
<td data-start="2371" data-end="2408" data-col-size="md">Neuroendocrine Regulatory Networks</td>
<td data-col-size="md" data-start="2408" data-end="2482">Examined for hypothalamic and central melanocortin system interactions</td>
</tr>
<tr data-start="2483" data-end="2608">
<td data-start="2483" data-end="2525" data-col-size="md">Energy Homeostasis &amp; Appetite Signaling</td>
<td data-col-size="md" data-start="2525" data-end="2608">Studied in preclinical animal models to assess melanocortin receptor modulation</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="2610" data-end="2613" />
<h2 data-start="2615" data-end="2639">Research Applications</h2>
<p data-start="2641" data-end="2702">Melanotan II is commonly employed in laboratory research for:</p>
<ul data-start="2704" data-end="3010">
<li data-start="2704" data-end="2772">
<p data-start="2706" data-end="2772">In vitro and in vivo <strong data-start="2727" data-end="2770">melanocortin receptor signaling studies</strong></p>
</li>
<li data-start="2773" data-end="2826">
<p data-start="2775" data-end="2826">Preclinical <strong data-start="2787" data-end="2824">melanocyte biology investigations</strong></p>
</li>
<li data-start="2827" data-end="2898">
<p data-start="2829" data-end="2898">Neuroendocrine network and <strong data-start="2856" data-end="2896">central melanocortin system research</strong></p>
</li>
<li data-start="2899" data-end="2961">
<p data-start="2901" data-end="2961">Signal transduction analyses of <strong data-start="2933" data-end="2959">cAMP-mediated pathways</strong></p>
</li>
<li data-start="2962" data-end="3010">
<p data-start="2964" data-end="3010">Comparative peptide receptor binding studies</p>
</li>
</ul>
<p data-start="3012" data-end="3234"><strong data-start="3012" data-end="3021">Note:</strong> All applications are <strong data-start="3043" data-end="3104">restricted to preclinical research and laboratory studies</strong>. Melanotan II is <strong data-start="3122" data-end="3166">not intended for human or veterinary use</strong>, and research should comply with all relevant safety regulations.</p>
<hr data-start="3236" data-end="3239" />
<h2 data-start="3241" data-end="3275">Storage and Handling Guidelines</h2>
<p data-start="3277" data-end="3494">Store Melanotan II in a <strong data-start="3301" data-end="3326">cool, dry environment</strong>, protected from light. Maintain <strong data-start="3359" data-end="3401">laboratory-standard storage conditions</strong> to preserve peptide integrity. Handle using <strong data-start="3446" data-end="3491">institutional laboratory safety protocols</strong>.</p>
<hr data-start="3496" data-end="3499" />
<h2 data-start="3501" data-end="3522">Lyophilized Powder</h2>
<p data-start="3524" data-end="3783">Melanotan II is provided as a <strong data-start="3554" data-end="3576">lyophilized powder</strong>, produced via freeze-drying to remove moisture while preserving peptide conformation. Lyophilization supports <strong data-start="3687" data-end="3746">accurate dosing in research studies and reproducibility</strong> in controlled experimental setups.</p>
<hr data-start="3785" data-end="3788" />
<h2 data-start="3790" data-end="3824">Shelf Life After Reconstitution</h2>
<p data-start="3826" data-end="4232">Following reconstitution, Melanotan II is no longer in its lyophilized state. <strong data-start="3904" data-end="3988">Stability is influenced by solvent, storage temperature, and handling conditions</strong>. Reconstituted material is generally suitable for <strong data-start="4039" data-end="4068">short-term laboratory use</strong>, with stability considerations incorporated into experimental planning. Actual usable duration may vary depending on <strong data-start="4186" data-end="4229">research-specific environmental factors</strong>.</p>
<hr data-start="4234" data-end="4237" />
<h3 data-start="4239" data-end="4260">Compliance Notice</h3>
<p data-start="4262" data-end="4545">Melanotan II is supplied <strong data-start="4287" data-end="4342">exclusively for laboratory and preclinical research</strong>. It is <strong data-start="4350" data-end="4420">not intended for human, therapeutic, veterinary, or diagnostic use</strong>. Purchasers must adhere to all applicable regulatory, safety, and institutional guidelines for handling research peptides.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://moleculepeptides.com/product/melanotan-ii/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>KissPeptin</title>
		<link>https://moleculepeptides.com/product/kisspeptin/</link>
					<comments>https://moleculepeptides.com/product/kisspeptin/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 23:52:06 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=266</guid>

					<description><![CDATA[Kisspeptin is a peptide hormone that may support reproductive health and hormonal balance. Available in 10mg size.]]></description>
										<content:encoded><![CDATA[<div style="" class="relative basis-auto flex-col -mb-(--composer-overlap-px) [--composer-overlap-px:28px] grow flex">
<div class="flex flex-col text-sm @w-xl/main:pt-header-height pb-25">
<article class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id="request-WEB:ac8ad9ac-0cc4-4bd8-92e3-0d4f8218bdaa-31" data-testid="conversation-turn-56" data-scroll-anchor="true" data-turn="assistant">
<div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] @w-sm/main:[--thread-content-margin:--spacing(6)] @w-lg/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)">
<div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn" tabindex="-1">
<div class="flex max-w-full flex-col grow">
<div class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1" dir="auto" data-message-author-role="assistant" data-message-id="1319150a-63f0-4195-b122-fe7ef1bd37bf" data-message-model-slug="gpt-5-mini">
<div class="flex w-full flex-col gap-1 empty:hidden first:pt-[1px]">
<div class="markdown prose dark:prose-invert w-full break-words light markdown-new-styling">
<h2 data-start="213" data-end="228">KissPeptin (Kisspeptin)</h2>
<p data-start="229" data-end="264"><strong data-start="229" data-end="264">Synthetic Peptide Research Tool</strong></p>
<p data-start="266" data-end="626">Kisspeptin is a <strong data-start="282" data-end="303">synthetic peptide</strong> derived from the KISS1 gene, widely utilized in laboratory and preclinical research to study <strong data-start="397" data-end="458">neuroendocrine signaling and reproductive axis regulation</strong>. It functions as a ligand for the <strong data-start="493" data-end="538">G-protein coupled receptor GPR54 (KISS1R)</strong>, enabling exploration of downstream signaling pathways in cellular and animal models.</p>
<p data-start="628" data-end="990">Kisspeptin research focuses on <strong data-start="659" data-end="785">mechanistic investigation of peptide-receptor interactions, hormonal regulatory networks, and neuroendocrine communication</strong>, rather than clinical or therapeutic outcomes. Preclinical studies have examined its role in <strong data-start="879" data-end="987">reproductive hormone modulation, hypothalamic-pituitary signaling, and associated intracellular pathways</strong>.</p>
<hr data-start="992" data-end="995" />
<h2 data-start="997" data-end="1038">Peptide Identity and Molecular Profile</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1040" data-end="1496">
<thead data-start="1040" data-end="1066">
<tr data-start="1040" data-end="1066">
<th data-start="1040" data-end="1051" data-col-size="sm">Property</th>
<th data-start="1051" data-end="1066" data-col-size="md">Description</th>
</tr>
</thead>
<tbody data-start="1094" data-end="1496">
<tr data-start="1094" data-end="1162">
<td data-start="1094" data-end="1109" data-col-size="sm">Peptide Name</td>
<td data-col-size="md" data-start="1109" data-end="1162">Kisspeptin-10 / Kisspeptin-54 (varies by isoform)</td>
</tr>
<tr data-start="1163" data-end="1205">
<td data-start="1163" data-end="1179" data-col-size="sm">Peptide Class</td>
<td data-col-size="md" data-start="1179" data-end="1205">Synthetic neuropeptide</td>
</tr>
<tr data-start="1206" data-end="1264">
<td data-start="1206" data-end="1226" data-col-size="sm">Amino Acid Length</td>
<td data-col-size="md" data-start="1226" data-end="1264">10–54 residues (isoform-dependent)</td>
</tr>
<tr data-start="1265" data-end="1342">
<td data-start="1265" data-end="1284" data-col-size="sm">Peptide Sequence</td>
<td data-col-size="md" data-start="1284" data-end="1342">Kisspeptin-10: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe</td>
</tr>
<tr data-start="1343" data-end="1401">
<td data-start="1343" data-end="1362" data-col-size="sm">Molecular Weight</td>
<td data-col-size="md" data-start="1362" data-end="1401">~1,500–6,400 Da (isoform-dependent)</td>
</tr>
<tr data-start="1402" data-end="1496">
<td data-start="1402" data-end="1422" data-col-size="sm">Biological Origin</td>
<td data-col-size="md" data-start="1422" data-end="1496">Encoded by the KISS1 gene, naturally expressed in hypothalamic neurons</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1498" data-end="1501" />
<h2 data-start="1503" data-end="1539">Chemical and Registry Information</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1541" data-end="1877">
<thead data-start="1541" data-end="1561">
<tr data-start="1541" data-end="1561">
<th data-start="1541" data-end="1552" data-col-size="sm">Property</th>
<th data-start="1552" data-end="1561" data-col-size="md">Value</th>
</tr>
</thead>
<tbody data-start="1583" data-end="1877">
<tr data-start="1583" data-end="1671">
<td data-start="1583" data-end="1603" data-col-size="sm">Molecular Formula</td>
<td data-col-size="md" data-start="1603" data-end="1671">Reported in research literature; varies by isoform and salt form</td>
</tr>
<tr data-start="1672" data-end="1716">
<td data-start="1672" data-end="1685" data-col-size="sm">CAS Number</td>
<td data-col-size="md" data-start="1685" data-end="1716">129906-86-3 (Kisspeptin-10)</td>
</tr>
<tr data-start="1717" data-end="1743">
<td data-start="1717" data-end="1731" data-col-size="sm">PubChem CID</td>
<td data-col-size="md" data-start="1731" data-end="1743">16132947</td>
</tr>
<tr data-start="1744" data-end="1808">
<td data-start="1744" data-end="1755" data-col-size="sm">Synonyms</td>
<td data-col-size="md" data-start="1755" data-end="1808">Kisspeptin, metastin, KISS1 peptide, KP-10, KP-54</td>
</tr>
<tr data-start="1809" data-end="1877">
<td data-start="1809" data-end="1824" data-col-size="sm">Source Notes</td>
<td data-col-size="md" data-start="1824" data-end="1877">Synthetic, laboratory-grade, research-use peptide</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1879" data-end="1882" />
<h2 data-start="1884" data-end="1937">Biological Pathways Studied (Preclinical Research)</h2>
<p data-start="1939" data-end="2140">In preclinical research, Kisspeptin has been explored for its effects on <strong data-start="2012" data-end="2087">cellular signaling, hormonal networks, and reproductive axis regulation</strong>, with a focus on molecular and mechanistic outcomes:</p>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="2142" data-end="2879">
<thead data-start="2142" data-end="2181">
<tr data-start="2142" data-end="2181">
<th data-start="2142" data-end="2161" data-col-size="md">Pathway / System</th>
<th data-start="2161" data-end="2181" data-col-size="lg">Research Context</th>
</tr>
</thead>
<tbody data-start="2220" data-end="2879">
<tr data-start="2220" data-end="2343">
<td data-start="2220" data-end="2245" data-col-size="md">GPR54/KISS1R Signaling</td>
<td data-start="2245" data-end="2343" data-col-size="lg">Investigated as a primary ligand for the KISS1 receptor (GPCR-mediated intracellular pathways)</td>
</tr>
<tr data-start="2344" data-end="2513">
<td data-start="2344" data-end="2388" data-col-size="md">Hypothalamic-Pituitary-Gonadal (HPG) Axis</td>
<td data-col-size="lg" data-start="2388" data-end="2513">Studied in preclinical models to explore gonadotropin-releasing hormone (GnRH) modulation and downstream LH/FSH signaling</td>
</tr>
<tr data-start="2514" data-end="2635">
<td data-start="2514" data-end="2548" data-col-size="md">Intracellular Calcium Signaling</td>
<td data-col-size="lg" data-start="2548" data-end="2635">Explored for roles in GPCR-mediated Ca²⁺ mobilization and second messenger cascades</td>
</tr>
<tr data-start="2636" data-end="2750">
<td data-start="2636" data-end="2670" data-col-size="md">Reproductive Hormone Regulation</td>
<td data-col-size="lg" data-start="2670" data-end="2750">Examined in vitro and in vivo for effects on gonadotropin secretion dynamics</td>
</tr>
<tr data-start="2751" data-end="2879">
<td data-start="2751" data-end="2789" data-col-size="md">Neuroendocrine Network Interactions</td>
<td data-col-size="lg" data-start="2789" data-end="2879">Studied in relation to hypothalamic neuron communication and regulatory feedback loops</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="2881" data-end="2884" />
<h2 data-start="2886" data-end="2910">Research Applications</h2>
<p data-start="2912" data-end="2971">Kisspeptin is commonly employed in laboratory research for:</p>
<ul data-start="2973" data-end="3293">
<li data-start="2973" data-end="3036">
<p data-start="2975" data-end="3036">Studying <strong data-start="2984" data-end="3011">GnRH release mechanisms</strong> in hypothalamic models</p>
</li>
<li data-start="3037" data-end="3097">
<p data-start="3039" data-end="3097">Investigating <strong data-start="3053" data-end="3095">GPR54-mediated intracellular signaling</strong></p>
</li>
<li data-start="3098" data-end="3173">
<p data-start="3100" data-end="3173">Preclinical exploration of <strong data-start="3127" data-end="3171">reproductive hormone regulatory networks</strong></p>
</li>
<li data-start="3174" data-end="3230">
<p data-start="3176" data-end="3230">Neuroendocrine and hypothalamic cell culture studies</p>
</li>
<li data-start="3231" data-end="3293">
<p data-start="3233" data-end="3293">Comparative analyses of peptide isoform signaling dynamics</p>
</li>
</ul>
<p data-start="3295" data-end="3465"><strong data-start="3295" data-end="3304">Note:</strong> All applications are restricted to <strong data-start="3340" data-end="3385">preclinical, in vitro, or animal research</strong>. Kisspeptin is <strong data-start="3401" data-end="3462">not intended for therapeutic, diagnostic, or clinical use</strong>.</p>
<hr data-start="3467" data-end="3470" />
<h2 data-start="3472" data-end="3506">Storage and Handling Guidelines</h2>
<p data-start="3508" data-end="3731">Store Kisspeptin in a <strong data-start="3530" data-end="3577">cool, dry environment, protected from light</strong>. Maintain standard laboratory storage and handling practices to preserve peptide stability. Handle all peptides under <strong data-start="3696" data-end="3730">institutional safety protocols</strong>.</p>
<hr data-start="3733" data-end="3736" />
<h2 data-start="3738" data-end="3759">Lyophilized Powder</h2>
<p data-start="3761" data-end="4047">Kisspeptin is provided as a <strong data-start="3789" data-end="3811">lyophilized powder</strong>, produced via freeze-drying to remove residual moisture while maintaining peptide conformation and chemical stability. Lyophilized peptide supports <strong data-start="3960" data-end="4007">accurate quantification and reproducibility</strong> in controlled laboratory experiments.</p>
<hr data-start="4049" data-end="4052" />
<h2 data-start="4054" data-end="4088">Shelf Life After Reconstitution</h2>
<p data-start="4090" data-end="4493">Following reconstitution, Kisspeptin is no longer in its dry state, and <strong data-start="4162" data-end="4263">stability is dependent on storage conditions, solvent choice, temperature, and handling practices</strong>. Reconstituted material is generally considered suitable for <strong data-start="4325" data-end="4354">short-term laboratory use</strong>, with planning for stability incorporated into experimental design. Actual usability may vary according to specific research conditions.</p>
<hr data-start="4495" data-end="4498" />
<h3 data-start="4500" data-end="4521">Compliance Notice</h3>
<p data-start="4523" data-end="4783">Kisspeptin is supplied <strong data-start="4546" data-end="4601">exclusively for laboratory and preclinical research</strong>. It is <strong data-start="4609" data-end="4679">not intended for human, veterinary, therapeutic, or diagnostic use</strong>, and purchasers must adhere to all relevant regulatory and safety requirements for research peptides.</p>
</div>
</div>
</div>
</div>
</div>
</div>
</article>
</div>
</div>
]]></content:encoded>
					
					<wfw:commentRss>https://moleculepeptides.com/product/kisspeptin/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>GHK-Cu</title>
		<link>https://moleculepeptides.com/product/ghk-cu/</link>
					<comments>https://moleculepeptides.com/product/ghk-cu/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 23:52:05 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=263</guid>

					<description><![CDATA[GHK-Cu (Copper Peptide) may support skin health, wound healing, and anti-aging benefits.]]></description>
										<content:encoded><![CDATA[<h2 style="" data-start="213" data-end="224">GHK-Cu</h2>
<p data-start="225" data-end="260"><strong data-start="225" data-end="260">Synthetic Peptide Research Tool</strong></p>
<p data-start="262" data-end="514">GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is a <strong data-start="318" data-end="365">synthetic tripeptide conjugated with copper</strong>, widely utilized in laboratory and preclinical studies to investigate <strong data-start="436" data-end="511">cellular signaling, extracellular matrix regulation, and tissue biology</strong>.</p>
<p data-start="516" data-end="861">Preclinical research explores GHK-Cu as a <strong data-start="558" data-end="680">modulator of molecular pathways associated with metal ion-dependent signaling, gene expression, and enzymatic activity</strong>. Investigations typically focus on <strong data-start="716" data-end="819">cellular repair models, matrix metalloproteinase regulation, and oxidative stress-related signaling</strong>, without implying therapeutic outcomes.</p>
<hr data-start="863" data-end="866" />
<h2 data-start="868" data-end="909">Peptide Identity and Molecular Profile</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="911" data-end="1280">
<thead data-start="911" data-end="937">
<tr data-start="911" data-end="937">
<th data-start="911" data-end="922" data-col-size="sm">Property</th>
<th data-start="922" data-end="937" data-col-size="md">Description</th>
</tr>
</thead>
<tbody data-start="965" data-end="1280">
<tr data-start="965" data-end="990">
<td data-start="965" data-end="980" data-col-size="sm">Peptide Name</td>
<td data-start="980" data-end="990" data-col-size="md">GHK-Cu</td>
</tr>
<tr data-start="991" data-end="1045">
<td data-start="991" data-end="1007" data-col-size="sm">Peptide Class</td>
<td data-col-size="md" data-start="1007" data-end="1045">Synthetic tripeptide–metal complex</td>
</tr>
<tr data-start="1046" data-end="1099">
<td data-start="1046" data-end="1066" data-col-size="sm">Amino Acid Length</td>
<td data-col-size="md" data-start="1066" data-end="1099">3 residues (copper-complexed)</td>
</tr>
<tr data-start="1100" data-end="1139">
<td data-start="1100" data-end="1119" data-col-size="sm">Peptide Sequence</td>
<td data-col-size="md" data-start="1119" data-end="1139">Gly-His-Lys-Cu²⁺</td>
</tr>
<tr data-start="1140" data-end="1192">
<td data-start="1140" data-end="1159" data-col-size="sm">Molecular Weight</td>
<td data-start="1159" data-end="1192" data-col-size="md">~404 Da, copper‑complexed form</td>
</tr>
<tr data-start="1193" data-end="1280">
<td data-start="1193" data-end="1213" data-col-size="sm">Biological Origin</td>
<td data-col-size="md" data-start="1213" data-end="1280">Synthetic analog of naturally occurring human plasma tripeptide</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1282" data-end="1285" />
<h2 data-start="1287" data-end="1323">Chemical and Registry Information</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1325" data-end="1586">
<thead data-start="1325" data-end="1345">
<tr data-start="1325" data-end="1345">
<th data-start="1325" data-end="1336" data-col-size="sm">Property</th>
<th data-start="1336" data-end="1345" data-col-size="md">Value</th>
</tr>
</thead>
<tbody data-start="1367" data-end="1586">
<tr data-start="1367" data-end="1403">
<td data-start="1367" data-end="1387" data-col-size="sm">Molecular Formula</td>
<td data-col-size="md" data-start="1387" data-end="1403">C₁₄H₂₄N₆O₄Cu</td>
</tr>
<tr data-start="1404" data-end="1431">
<td data-start="1404" data-end="1417" data-col-size="sm">CAS Number</td>
<td data-col-size="md" data-start="1417" data-end="1431">49557-75-7</td>
</tr>
<tr data-start="1432" data-end="1457">
<td data-start="1432" data-end="1446" data-col-size="sm">PubChem CID</td>
<td data-start="1446" data-end="1457" data-col-size="md">5281809</td>
</tr>
<tr data-start="1458" data-end="1522">
<td data-start="1458" data-end="1469" data-col-size="sm">Synonyms</td>
<td data-start="1469" data-end="1522" data-col-size="md">GHK-Cu, Glycyl-L-Histidyl-L-Lysine copper complex</td>
</tr>
<tr data-start="1523" data-end="1586">
<td data-start="1523" data-end="1538" data-col-size="sm">Source Notes</td>
<td data-col-size="md" data-start="1538" data-end="1586">Laboratory-grade, synthetic research peptide</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="1588" data-end="1591" />
<h2 data-start="1593" data-end="1646">Biological Pathways Studied (Preclinical Research)</h2>
<p data-start="1648" data-end="1802">In preclinical and in vitro studies, GHK-Cu has been investigated for its interactions with <strong data-start="1740" data-end="1801">cellular regulatory and metal-dependent signaling systems</strong>:</p>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1804" data-end="2485">
<thead data-start="1804" data-end="1843">
<tr data-start="1804" data-end="1843">
<th data-start="1804" data-end="1823" data-col-size="sm">Pathway / System</th>
<th data-start="1823" data-end="1843" data-col-size="lg">Research Context</th>
</tr>
</thead>
<tbody data-start="1882" data-end="2485">
<tr data-start="1882" data-end="1993">
<td data-start="1882" data-end="1916" data-col-size="sm">Extracellular Matrix Modulation</td>
<td data-col-size="lg" data-start="1916" data-end="1993">Studied for influence on collagen, elastin, and matrix metalloproteinases</td>
</tr>
<tr data-start="1994" data-end="2102">
<td data-start="1994" data-end="2023" data-col-size="sm">Copper-Dependent Signaling</td>
<td data-col-size="lg" data-start="2023" data-end="2102">Explored as a metal-peptide complex influencing enzymatic cofactor activity</td>
</tr>
<tr data-start="2103" data-end="2216">
<td data-start="2103" data-end="2130" data-col-size="sm">Cellular Stress Response</td>
<td data-col-size="lg" data-start="2130" data-end="2216">Investigated for gene expression changes associated with oxidative stress pathways</td>
</tr>
<tr data-start="2217" data-end="2340">
<td data-start="2217" data-end="2253" data-col-size="sm">Tissue Remodeling &amp; Repair Models</td>
<td data-col-size="lg" data-start="2253" data-end="2340">Studied in fibroblast and epithelial cell models to assess matrix-related signaling</td>
</tr>
<tr data-start="2341" data-end="2485">
<td data-start="2341" data-end="2368" data-col-size="sm">Gene Regulation Networks</td>
<td data-col-size="lg" data-start="2368" data-end="2485">Examined for transcriptional modulation of genes involved in proliferation, differentiation, and tissue structure</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="2487" data-end="2490" />
<h2 data-start="2492" data-end="2516">Research Applications</h2>
<p data-start="2518" data-end="2573">GHK-Cu is commonly employed in laboratory research for:</p>
<ul data-start="2575" data-end="2912">
<li data-start="2575" data-end="2647">
<p data-start="2577" data-end="2647">Preclinical <strong data-start="2589" data-end="2645">extracellular matrix and collagen regulation studies</strong></p>
</li>
<li data-start="2648" data-end="2710">
<p data-start="2650" data-end="2710">Cellular assays for <strong data-start="2670" data-end="2708">metal-dependent enzymatic activity</strong></p>
</li>
<li data-start="2711" data-end="2769">
<p data-start="2713" data-end="2769">Fibroblast and epithelial <strong data-start="2739" data-end="2767">tissue remodeling models</strong></p>
</li>
<li data-start="2770" data-end="2835">
<p data-start="2772" data-end="2835">Investigations of <strong data-start="2790" data-end="2833">gene expression and regulatory networks</strong></p>
</li>
<li data-start="2836" data-end="2912">
<p data-start="2838" data-end="2912">In vitro studies of <strong data-start="2858" data-end="2910">oxidative stress response and cellular signaling</strong></p>
</li>
</ul>
<p data-start="2914" data-end="3064"><strong data-start="2914" data-end="2923">Note:</strong> All applications are restricted to <strong data-start="2959" data-end="3005">preclinical research and laboratory models</strong>. GHK-Cu is <strong data-start="3017" data-end="3061">not intended for human or veterinary use</strong>.</p>
<hr data-start="3066" data-end="3069" />
<h2 data-start="3071" data-end="3105">Storage and Handling Guidelines</h2>
<p data-start="3107" data-end="3321">Store GHK-Cu in a <strong data-start="3125" data-end="3144">cool, dry place</strong>, protected from light and moisture. Maintain standard laboratory storage conditions to preserve peptide stability. Handle using <strong data-start="3273" data-end="3318">institutional laboratory safety protocols</strong>.</p>
<hr data-start="3323" data-end="3326" />
<h2 data-start="3328" data-end="3349">Lyophilized Powder</h2>
<p data-start="3351" data-end="3622">GHK-Cu is supplied as a <strong data-start="3375" data-end="3397">lyophilized powder</strong>, produced through freeze-drying to minimize residual moisture while preserving peptide conformation and metal complex integrity. This format supports <strong data-start="3548" data-end="3594">precise quantification and reproducibility</strong> in experimental settings.</p>
<hr data-start="3624" data-end="3627" />
<h2 data-start="3629" data-end="3663">Shelf Life After Reconstitution</h2>
<p data-start="3665" data-end="4039">Once reconstituted, GHK-Cu no longer retains the dry-state stability. Reconstituted material is generally suitable for <strong data-start="3784" data-end="3813">short-term laboratory use</strong>, with stability influenced by solvent choice, storage temperature, and handling conditions. Laboratory planning should consider <strong data-start="3942" data-end="3975">post-reconstitution stability</strong> as part of experimental design and data integrity management.</p>
<hr data-start="4041" data-end="4044" />
<h3 data-start="4046" data-end="4067">Compliance Notice</h3>
<p data-start="4069" data-end="4335">GHK-Cu is supplied <strong data-start="4088" data-end="4152">exclusively for laboratory and preclinical research purposes</strong>. It is <strong data-start="4160" data-end="4239">not intended for human, therapeutic, veterinary, or diagnostic applications</strong>. All handling must adhere to applicable <strong data-start="4280" data-end="4332">regulatory, institutional, and safety guidelines</strong>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://moleculepeptides.com/product/ghk-cu/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>GLOW</title>
		<link>https://moleculepeptides.com/product/glow/</link>
					<comments>https://moleculepeptides.com/product/glow/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 23:52:05 +0000</pubDate>
				<guid isPermaLink="false">https://moleculepeptides.com/?post_type=product&#038;p=262</guid>

					<description><![CDATA[GLOW is a peptide blend containing GHK-Cu, BPC-157, and TB-500, designed to support skin health and radiance. Available in 70mg size.]]></description>
										<content:encoded><![CDATA[<h2 style="" data-start="145" data-end="154">GLOW</h2>
<p data-start="155" data-end="190"><strong data-start="155" data-end="190">Synthetic Peptide Research Tool</strong></p>
<p data-start="192" data-end="581">GLOW is a proprietary blend of BPC‑157, TB‑500, and GHK‑Cu formulated for research use and studied in laboratory and preclinical research as a tool for investigating <strong data-start="299" data-end="390">cellular signaling, extracellular matrix regulation, and bioactive peptide interactions</strong>. Research primarily explores its role in <strong data-start="432" data-end="527">cellular communication networks, peptide-mediated signaling, and gene expression modulation</strong>, without implying therapeutic or clinical outcomes.</p>
<p data-start="583" data-end="861">Preclinical studies focus on GLOW’s involvement in <strong data-start="634" data-end="762">cellular proliferation, metabolic signaling, and regulatory pathways associated with oxidative stress and tissue homeostasis</strong>. Investigations are typically performed in <strong data-start="806" data-end="858">in vitro models and controlled laboratory assays</strong>.</p>
<hr data-start="863" data-end="866" />
<h2 data-start="868" data-end="909">Peptide Identity and Molecular Profile</h2>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">See BPC‑157, TB‑500, GHK‑Cu Components</div>
<div tabindex="-1"></div>
</div>
<hr data-start="1330" data-end="1333" />
<h2 data-start="1335" data-end="1371">Chemical and Registry Information</h2>
<div class="TyagGW_tableContainer">See BPC‑157, TB‑500, GHK‑Cu Components</div>
<div></div>
<hr data-start="1713" data-end="1716" />
<h2 data-start="1718" data-end="1771">Biological Pathways Studied (Preclinical Research)</h2>
<p data-start="1773" data-end="1887">In preclinical research, GLOW has been studied for interactions with <strong data-start="1842" data-end="1886">molecular and cellular signaling systems</strong>:</p>
<div class="TyagGW_tableContainer">
<div class="group TyagGW_tableWrapper flex w-fit flex-col-reverse" tabindex="-1">
<table class="w-fit min-w-(--thread-content-width)" data-start="1889" data-end="2572">
<thead data-start="1889" data-end="1928">
<tr data-start="1889" data-end="1928">
<th data-start="1889" data-end="1908" data-col-size="sm">Pathway / System</th>
<th data-start="1908" data-end="1928" data-col-size="lg">Research Context</th>
</tr>
</thead>
<tbody data-start="1967" data-end="2572">
<tr data-start="1967" data-end="2080">
<td data-start="1967" data-end="2001" data-col-size="sm">Extracellular Matrix Regulation</td>
<td data-col-size="lg" data-start="2001" data-end="2080">Investigated in relation to collagen, elastin, and matrix-modifying enzymes</td>
</tr>
<tr data-start="2081" data-end="2192">
<td data-start="2081" data-end="2110" data-col-size="sm">Peptide Receptor Signaling</td>
<td data-col-size="lg" data-start="2110" data-end="2192">Studied in vitro for modulation of GPCRs and peptide hormone receptor pathways</td>
</tr>
<tr data-start="2193" data-end="2315">
<td data-start="2193" data-end="2220" data-col-size="sm">Cellular Stress Response</td>
<td data-col-size="lg" data-start="2220" data-end="2315">Explored for roles in oxidative stress, antioxidant signaling, and gene expression networks</td>
</tr>
<tr data-start="2316" data-end="2451">
<td data-start="2316" data-end="2337" data-col-size="sm">Tissue Homeostasis</td>
<td data-col-size="lg" data-start="2337" data-end="2451">Examined in fibroblast and epithelial models for regulation of cellular proliferation and structural integrity</td>
</tr>
<tr data-start="2452" data-end="2572">
<td data-start="2452" data-end="2474" data-col-size="sm">Metabolic Signaling</td>
<td data-start="2474" data-end="2572" data-col-size="lg">Investigated for involvement in intracellular energy-sensing and metabolic regulatory pathways</td>
</tr>
</tbody>
</table>
</div>
</div>
<hr data-start="2574" data-end="2577" />
<h2 data-start="2579" data-end="2603">Research Applications</h2>
<p data-start="2605" data-end="2661">GLOW is commonly used in laboratory research, including:</p>
<ul data-start="2663" data-end="2988">
<li data-start="2663" data-end="2734">
<p data-start="2665" data-end="2734">Preclinical <strong data-start="2677" data-end="2732">extracellular matrix and structural protein studies</strong></p>
</li>
<li data-start="2735" data-end="2793">
<p data-start="2737" data-end="2793">In vitro <strong data-start="2746" data-end="2791">peptide-receptor signaling investigations</strong></p>
</li>
<li data-start="2794" data-end="2862">
<p data-start="2796" data-end="2862">Studies of <strong data-start="2807" data-end="2860">cellular stress response and antioxidant pathways</strong></p>
</li>
<li data-start="2863" data-end="2937">
<p data-start="2865" data-end="2937">Laboratory models of <strong data-start="2886" data-end="2935">tissue homeostasis and cellular proliferation</strong></p>
</li>
<li data-start="2938" data-end="2988">
<p data-start="2940" data-end="2988">Research into <strong data-start="2954" data-end="2986">metabolic signaling networks</strong></p>
</li>
</ul>
<p data-start="2990" data-end="3145"><strong data-start="2990" data-end="2999">Note:</strong> GLOW is intended solely for <strong data-start="3028" data-end="3073">preclinical research and in vitro studies</strong>. It is <strong data-start="3081" data-end="3142">not for human, veterinary, diagnostic, or therapeutic use</strong>.</p>
<hr data-start="3147" data-end="3150" />
<h2 data-start="3152" data-end="3186">Storage and Handling Guidelines</h2>
<p data-start="3188" data-end="3407">Store GLOW in a <strong data-start="3204" data-end="3229">cool, dry environment</strong>, protected from light. Maintain standard laboratory conditions to preserve peptide stability. Handle all research peptides using <strong data-start="3359" data-end="3404">institutional laboratory safety protocols</strong>.</p>
<hr data-start="3409" data-end="3412" />
<h2 data-start="3414" data-end="3435">Lyophilized Powder</h2>
<p data-start="3437" data-end="3688">GLOW is supplied as a <strong data-start="3459" data-end="3481">lyophilized powder</strong>, which reduces residual moisture and maintains peptide conformation for reliable experimental reproducibility. Lyophilization ensures consistent peptide concentration and handling in preclinical research.</p>
<hr data-start="3690" data-end="3693" />
<h2 data-start="3695" data-end="3729">Shelf Life After Reconstitution</h2>
<p data-start="3731" data-end="4016">Once reconstituted, GLOW should be considered for <strong data-start="3781" data-end="3810">short-term laboratory use</strong>. Stability may vary depending on <strong data-start="3844" data-end="3893">solvent, temperature, and handling conditions</strong>. Researchers should incorporate post-reconstitution stability into experimental planning to maintain <strong data-start="3995" data-end="4013">data integrity</strong>.</p>
<hr data-start="4018" data-end="4021" />
<h3 data-start="4023" data-end="4044">Compliance Notice</h3>
<p data-start="4046" data-end="4290">GLOW is provided <strong data-start="4063" data-end="4127">exclusively for laboratory and preclinical research purposes</strong>. It is <strong data-start="4135" data-end="4205">not intended for human, veterinary, therapeutic, or diagnostic use</strong>. All handling must comply with <strong data-start="4237" data-end="4287">institutional and regulatory safety guidelines</strong>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://moleculepeptides.com/product/glow/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
